Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, May 1, 2013

Thrombectomy in Stroke: Reimbursable or Not

Your doctor uses this to save your life and the insurance company denies reimbursement. You had better start screaming at the insurance companies, its probably cheaper for them to have you die. At least your doctor would get paid if you die, remember there is no pay for results.
http://www.medpagetoday.com/Cardiology/Strokes/38610?
Several recent trials have shown the effectiveness of thrombectomy devices in the setting of ischemic stroke, but payment for use of the devices is not a guaranteed thing, according to an editorial in the journal Stroke.
"Insurance companies in the U.S. are currently considering whether the data from [the IMS III and SYNTHESIS trials] justify withdrawal of reimbursement for thrombectomy devices for all ischemic stroke patients, including those patients who arrive within the tPA treatment window but who are ineligible for IV tPA," wrote Joseph P. Broderick, MD, and Thomas A. Tomsick, MD, on behalf of the Interventional Management of Stroke (IMS) III executive committee.
Those trials did not show a benefit for endovascular therapy beyond what could be achieved with tPA.
But since the IMS III trial, many new-generation thrombectomy devices have been tested, albeit in smaller studies, showing good results.
The editorialists argue that if patients arrive within the 4.5 hour window when IV tPA is beneficial, but have contraindications for IV therapy, the use of thrombectomy devices for these patients should be reimbursed.

No comments:

Post a Comment